LongAXSMJun 2026
Axsome Therapeutics
Baird initiated a position in Axsome Therapeutics as one of three commercial-stage therapeutics companies added during the quarter. Axsome already has multiple marketed products…
AXSM
Which hedge funds are long AXSM?
2 published ideas on Axsome Therapeutics across 2 funds — 2 long and 0 short.
Each entry below comes from a hedge fund's own investor letter, not a 13F filing, so it carries the reasoning behind the position on Axsome Therapeutics: the full thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Funds with a position view
Long theses
LongAXSMJun 2026
Axsome Therapeutics
Baird added Axsome Therapeutics as one of several commercial-stage therapeutic companies with promising growth potential. The company already has multiple marketed products…